logo
AAT Bioquest

Deoxycholic acid-iFluor® 647 conjugate

Product Image
Product Image
Gallery Image 1
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
Molecular weight1253.63
SolventDMSO
Spectral properties
Correction Factor (260 nm)0.03
Correction Factor (280 nm)0.03
Correction Factor (656 nm)0.0793
Extinction coefficient (cm -1 M -1)2500001
Excitation (nm)656
Emission (nm)670
Quantum yield0.251
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC12171501

OverviewpdfSDSpdfProtocol


Molecular weight
1253.63
Correction Factor (260 nm)
0.03
Correction Factor (280 nm)
0.03
Correction Factor (656 nm)
0.0793
Extinction coefficient (cm -1 M -1)
2500001
Excitation (nm)
656
Emission (nm)
670
Quantum yield
0.251
Deoxycholic acid, also known as cholanoic acid is a bile acid. Deoxycholic acid-iFluor® 647 conjugate is a red fluorescent derivative of deoxycholic acid. It is an iFluor® 647-labeled bile acid derivative that closely parallels the cellular binding and uptake properties of deoxycholic acid. It is a divalent 'unipolar' anionic fluorescent bile salt analog that might offer a potentially useful probe for studying cellular mechanisms of deoxycholic acid at the hepatocellular level. Deoxycholic acid-iFluor® 647 conjugate can be used as a tool for the visualization of bile acid transport for the samples that have either strong blue or green fluorescence since its strong red fluorescence is well separated from blue or green fluorescence. Deoxycholic acid is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. The two primary bile acids secreted by the liver are cholic acid and chenodeoxycholic acid. Deoxycholic acid, under the brand name Kybella, is approved by the FDA for reducing moderate-to-severe fat below the chin. When injected into submental fat, deoxycholic acid helps destroy fat cells.

Calculators


Common stock solution preparation

Table 1. Volume of DMSO needed to reconstitute specific mass of Deoxycholic acid-iFluor® 647 conjugate to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

0.1 mg0.5 mg1 mg5 mg10 mg
1 mM79.768 µL398.842 µL797.684 µL3.988 mL7.977 mL
5 mM15.954 µL79.768 µL159.537 µL797.684 µL1.595 mL
10 mM7.977 µL39.884 µL79.768 µL398.842 µL797.684 µL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)Molecular weightVolume (Calculate)Concentration (Calculate)Moles
/=x=

Spectrum


Open in Advanced Spectrum Viewer
spectrum

Spectral properties

Correction Factor (260 nm)0.03
Correction Factor (280 nm)0.03
Correction Factor (656 nm)0.0793
Extinction coefficient (cm -1 M -1)2500001
Excitation (nm)656
Emission (nm)670
Quantum yield0.251

Images


References


View all 50 references: Citation Explorer
Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
Authors: Chen, Shanshan and Deng, Junjie and Zhang, Li-Ming
Journal: Carbohydrate polymers (2021): 117706
Deoxycholic Acid and Lithocholic Acid Alleviate Liver Injury and Inflammation in Mice with Klebsiella pneumoniae-Induced Liver Abscess and Bacteremia.
Authors: Zheng, Yahong and Yue, Chengcheng and Zhang, Hui and Chen, Haoran and Liu, Yanyan and Li, Jiabin
Journal: Journal of inflammation research (2021): 777-789
Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials.
Authors: Cunha, Karin Soares and Lima, Flávia and Cardoso, Roberta Marques
Journal: Expert review of clinical pharmacology (2021): 383-397
Free Deoxycholic Acid Exacerbates Vascular Calcification in CKD through ER Stress-Mediated ATF4 Activation.
Authors: Miyazaki-Anzai, Shinobu and Masuda, Masashi and Shiozaki, Yuji and Keenan, Audrey L and Chonchol, Michel and Kremoser, Claus and Miyazaki, Makoto
Journal: Kidney360 (2021): 857-868
pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery.
Authors: Zhang, Ya-Wen and Tu, Ling-Lan and Tang, Zhan and Wang, Qiao and Zheng, Gao-Li and Yin, Li-Na
Journal: Pharmaceutical development and technology (2021): 1-10
Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor.
Authors: Abrigo, Johanna and Gonzalez, Francisco and Aguirre, Francisco and Tacchi, Franco and Gonzalez, Andrea and Meza, María Paz and Simon, Felipe and Cabrera, Daniel and Arrese, Marco and Karpen, Saul and Cabello-Verrugio, Claudio
Journal: Journal of cellular physiology (2021): 260-272
Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid.
Authors: Majimbi, Maimuna and Brook, Emily and Galettis, Peter and Eden, Edward and Al-Salami, Hani and Mooranian, Armin and Al-Sallami, Hesham and Lam, Virginie and Mamo, John C L and Takechi, Ryusuke
Journal: PloS one (2021): e0243858
Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers.
Authors: Li, Xue-Qing and Thelingwani, Roslyn Stella and Bertilsson, Leif and Diczfalusy, Ulf and Andersson, Tommy B and Masimirembwa, Collen
Journal: Journal of personalized medicine (2021)
Design and synthesis of polyacrylic acid/deoxycholic acid-modified chitosan copolymer and a close inspection of human growth hormone-copolymer interactions: An experimental and computational study.
Authors: Khanmohammadi, Somayeh and Mehrnejad, Faramarz and Lotfi-Sousefi, Zahra and Yahyaei, Mohammad and Naderi-Manesh, Hossein
Journal: Colloids and surfaces. B, Biointerfaces (2021): 111956
Lesion reduction with intralesional deoxycholic acid in Dercum disease with radiographic evidence.
Authors: Rice, Shauna and Dalla Costa, Renata and Caravaglio, Joseph and Kourosh, A Shadi
Journal: JAAD case reports (2021): 73-75